Skip to main content

Nathanael C JensenAnna EdenJacob RobinsChristopher HullKeith DuffyAllyson SorensenLuke Johnson

Abstract

Background: In the treatment of keratinocyte carcinoma, curettage alone has been described as a simpler, less expensive, and quicker method than electrodessication and curettage; however, there are limited studies examining recurrence rates for such lesions.

Objective: To investigate the 5-year recurrence rates of keratinocyte carcinoma treated with curettage alone and compare these results to previously reported recurrence rates for electrodessication and curettage.

Patients and methods: A retrospective cohort and interview study determined 5-year recurrence rates for 1,853 total lesions treated with curettage alone using chart review data and patient phone calls.

Results: This study yielded a per-protocol 5-year recurrence rate of 2.41% for BCCs, 4.52% for SCCs, and an average of 3.71% across both types of keratinocyte carcinoma. Lesions on the head and neck displayed a significantly greater recurrence rate of 7.18% when treated with curettage alone.

Conclusion: Curettage alone provides comparable efficacy in curing keratinocyte carcinoma when compared with electrodessication and curettage.

To access the full article please visit this site.

MoleMax Systems
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.